AMIX
Income statement / Annual
Last year (2023), Autonomix Medical, Inc. Common Stock's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Autonomix Medical, Inc. Common Stock's net income was -$15.43 M.
See Autonomix Medical, Inc. Common Stock’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$81,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$81,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
| Research and Development
Expenses |
$2.23 M
|
$657,226.00
|
$4,069.00
|
| General & Administrative
Expenses |
$5.25 M
|
$1.25 M
|
$13.59 M
|
| Selling & Marketing
Expenses |
$0.00
|
$88,251.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.25 M
|
$1.33 M
|
$13.59 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$7.39 M |
$1.99 M |
$13.59 M |
| Cost And Expenses |
$7.47 M |
$1.99 M |
$13.59 M |
| Interest Income |
$127,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$79,000.00 |
$0.00 |
$218,088.00 |
| Depreciation &
Amortization |
$81,000.00
|
$1.99 M
|
$13.59 M
|
| EBITDA |
-$15.27 M
|
$0.00
|
$752,447.00
|
| EBITDA Ratio |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$7.95 M
|
$3.00
|
$265,560.00
|
| Income Before Tax |
-$15.43 M |
-$1.99 M |
-$13.33 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$1.99 M |
-$13.59 M |
| Net Income |
-$15.43 M |
-$1.99 M |
-$13.33 M |
| Net Income Ratio |
0 |
0 |
0 |
| EPS |
-1.05 |
-0.11 |
-0.71 |
| EPS Diluted |
-1.05 |
-0.11 |
-0.71 |
| Weighted Average Shares
Out |
$14.63 M
|
$18.79 M
|
$18.79 M
|
| Weighted Average Shares
Out Diluted |
$14.63 M
|
$18.79 M
|
$18.79 M
|
| Link |
|
|
|
